Zimmer Biomet Holdings Stock Performance
| ZBH Stock | USD 119.33 1.97 1.62% |
The firm maintains a market beta of 1.01, which attests to a somewhat significant risk relative to the market. Zimmer Biomet returns are very sensitive to returns on the market. As the market goes up or down, Zimmer Biomet is expected to follow. Zimmer Biomet Holdings has an expected return of -0.031%. Please make sure to check out Zimmer Biomet Holdings treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Zimmer Biomet Holdings performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Zimmer Biomet Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental drivers, Zimmer Biomet is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
Actual Historical Performance (%)
One Day Return (1.62) | Five Day Return (5.59) | Year To Date Return (1.70) | Ten Year Return 33.84 | All Time Return 313.34 |
Forward Dividend Yield 0.0079 | Payout Ratio 0.127 | Last Split Factor 103:100 | Forward Dividend Rate 0.96 | Dividend Date 2024-04-30 |
| Zimmer Biomet dividend paid on 31st of January 2024 | 01/31/2024 |
1 | Acquisition by Rachel Ellingson of 4697 shares of Zimmer Biomet subject to Rule 16b-3 | 02/20/2024 |
2 | Zimmer Biomet wins FDA clearance for ROSA Shoulder System | 02/22/2024 |
3 | Disposition of 2052 shares by Sang Yi of Zimmer Biomet subject to Rule 16b-3 | 03/01/2024 |
4 | Disposition of tradable shares by Lori Winkler of Zimmer Biomet at 124.28 subject to Rule 16b-3 | 03/05/2024 |
5 | China Dental Market Analysis, Size and Forecasts Report 2024 A 115 Billion Industry by 2030, Driven by Rising Geriatric Population, Poor Oral Health Epidemic, a... | 03/22/2024 |
6 | Global Electrosurgery Market Report 2024 Market to Reach 8.99 Billion by 2031 - In-Depth Analysis of Products, Surgeries, and End User Demand Forecasts | 03/25/2024 |
7 | 3M completes Solventum healthcare business spinoff | 04/01/2024 |
8 | Zimmer Biomet Holdings, Inc.s Has Had A Decent Run On The Stock market Are Fundamentals In The Drivers Seat | 04/02/2024 |
9 | Zimmer Biomet Becomes First and Only Official Medical Device Partner of Association of Pickleball Players, Professional Pickleball Association, and USA Pickleba... | 04/04/2024 |
10 | Why Zimmer Biomet is a Top Value Stock for the Long-Term | 04/10/2024 |
11 | SmithNephew Expands in Australia With New Alliance | 04/11/2024 |
12 | Zimmer Biomet Holdings NYSEZBH investor three-year losses grow to 26 percent as the stock sheds US1.5b this past week | 04/17/2024 |
| Begin Period Cash Flow | 375.7 M |
Zimmer |
Zimmer Biomet Relative Risk vs. Return Landscape
If you would invest 12,236 in Zimmer Biomet Holdings on January 20, 2024 and sell it today you would lose (303.00) from holding Zimmer Biomet Holdings or give up 2.48% of portfolio value over 90 days. Zimmer Biomet Holdings is generating negative expected returns assuming volatility of 1.3399% on return distribution over 90 days investment horizon. In other words, 11% of stocks are less volatile than Zimmer, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Zimmer Biomet Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zimmer Biomet's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Zimmer Biomet Holdings, and traders can use it to determine the average amount a Zimmer Biomet's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0231
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ZBH |
Estimated Market Risk
| 1.34 actual daily | 11 89% of assets are more volatile |
Expected Return
| -0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Zimmer Biomet is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zimmer Biomet by adding Zimmer Biomet to a well-diversified portfolio.
Zimmer Biomet Fundamentals Growth
Zimmer Stock prices reflect investors' perceptions of the future prospects and financial health of Zimmer Biomet, and Zimmer Biomet fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zimmer Stock performance.
| Return On Equity | 0.0836 | ||||
| Return On Asset | 0.044 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 30.68 B | ||||
| Shares Outstanding | 205.46 M | ||||
| Price To Earning | 77.41 X | ||||
| Price To Book | 2.05 X | ||||
| Price To Sales | 3.46 X | ||||
| Revenue | 7.39 B | ||||
| Gross Profit | 4.92 B | ||||
| EBITDA | 2.34 B | ||||
| Net Income | 1.02 B | ||||
| Cash And Equivalents | 375.7 M | ||||
| Cash Per Share | 2.71 X | ||||
| Total Debt | 6 B | ||||
| Debt To Equity | 0.48 % | ||||
| Current Ratio | 1.98 X | ||||
| Book Value Per Share | 60.70 X | ||||
| Cash Flow From Operations | 1.58 B | ||||
| Earnings Per Share | 4.88 X | ||||
| Market Capitalization | 24.51 B | ||||
| Total Asset | 21.5 B | ||||
| Retained Earnings | 10.38 B | ||||
| Working Capital | 1.75 B | ||||
| Current Asset | 5.85 B | ||||
| Current Liabilities | 1.62 B | ||||
About Zimmer Biomet Performance
To evaluate Zimmer Biomet Holdings Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Zimmer Biomet generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Zimmer Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Zimmer Biomet Holdings market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Zimmer's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 318.76 | 258.52 | |
| Return On Tangible Assets | 0.13 | 0.18 | |
| Return On Capital Employed | 0.07 | 0.07 | |
| Return On Assets | 0.05 | 0.05 | |
| Return On Equity | 0.08 | 0.08 |
Things to note about Zimmer Biomet Holdings performance evaluation
Checking the ongoing alerts about Zimmer Biomet for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zimmer Biomet Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Zimmer Biomet generated a negative expected return over the last 90 days | |
| Zimmer Biomet has a strong financial position based on the latest SEC filings | |
| Over 91.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from simplywall.st: Zimmer Biomet Holdings NYSEZBH investor three-year losses grow to 26 percent as the stock sheds US1.5b this past week |
- Analyzing Zimmer Biomet's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zimmer Biomet's stock is overvalued or undervalued compared to its peers.
- Examining Zimmer Biomet's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Zimmer Biomet's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zimmer Biomet's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Zimmer Biomet's stock. These opinions can provide insight into Zimmer Biomet's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Zimmer Biomet Holdings information on this page should be used as a complementary analysis to other Zimmer Biomet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Zimmer Stock analysis
When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is Zimmer Biomet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.16) | Dividend Share 0.96 | Earnings Share 4.88 | Revenue Per Share 35.43 | Quarterly Revenue Growth 0.063 |
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.